Abstract: The present disclosure provides for an immunogenic composition against epizootic hemorrhagic disease virus (EHDV). The immunogenic composition has been shown to be efficacious in inducing serum neutralizing antibodies against EHDV and intended to be used to prevent or reduce clinical symptoms associated with EHDV infection in susceptible animals. The disclosure provides for composition and methods that represent an improvement over previous strategies for treating and preventing EHDV.
Type:
Grant
Filed:
September 18, 2017
Date of Patent:
January 5, 2021
Assignees:
Kansas State University Research Foundation, The United States of America, as reoresented by The Secretary of Agriculture
Inventors:
Juergen A. Richt, Igor Morozov, Sun Young Sunwoo, William C. Wilson